Enzene obtains Marketing Authorization for its first Biosimilar molecule in India

Related solutions

Enzene obtains Marketing Authorization for its first Biosimilar molecule in India

Latest from Enzene

See more
Enzene Receives EU GMP Certification for its Facilities in India

Enzene Receives EU GMP Certification for its Facilities in India

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that its two facilit [...]

Learn more
Enzene Biosciences launches biosimilar Ranibizumab

Enzene Biosciences launches biosimilar Ranibizumab

Enzene Biosciences has now launched Ranibizumab, a biosimilar to innovator product Lucentis® that is sold under the bran [...]

Learn more
Enzene Biosciences launches biosimilar Adalimumab

Enzene Biosciences launches biosimilar Adalimumab

Enzene Biosciences Ltd. has announced that it has begun commercial supplies of Adalimumab for treating Ankylosis Spondyl [...]

Learn more

Join the revolution

Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.

Join the revolution